KAI vs MMS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Kadant Inc. presents a dichotomy between exceptional operational execution and severe valuation premiums. While the Piotroski F-Score of 4/9 indicates stable financial health and the company boasts a remarkable 25-quarter streak of earnings beats, the current price of $309.55 is trading at a massive premium to its Graham Number ($127.11) and Intrinsic Value ($60.48). Despite strong liquidity and low leverage, the flat year-over-year earnings growth (-0.10%) fails to justify the current P/E of 35.83. The stock is fundamentally sound but mathematically overextended.
Maximus, Inc. presents a classic value trap profile: fundamentally cheap with a stable Piotroski F-Score of 6/9, but plagued by negative revenue growth and bearish momentum. While the stock trades near its Graham Number ($68.01) and significantly below its growth-based intrinsic value, the divergence between surging earnings (+146.5%) and shrinking revenue (-4.1%) suggests profitability gains are driven by cost-cutting rather than organic expansion. Strong liquidity and a healthy ROE of 22.09% provide a safety floor, but the 0/100 technical trend and insider selling signal a lack of immediate catalyst.
Compare Another Pair
Related Comparisons
KAI vs MMS: Head-to-Head Comparison
This page compares Kadant Inc. (KAI) and Maximus, Inc. (MMS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.